BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 6632211)

  • 1. [Mode of spread of intrahepatic bile duct carcinoma].
    Kurashina M; Kozuka S; Nakashima N; Hirabayashi N
    Gan No Rinsho; 1983 Sep; 29(11):1314-8. PubMed ID: 6632211
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Carcinoma of the extrahepatic bile duct: mode of spread and its prognostic implications.
    Yamaguchi K; Chijiiwa K; Saiki S; Shimizu S; Takashima M; Tanaka M
    Hepatogastroenterology; 1997; 44(17):1256-61. PubMed ID: 9356836
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Surgical management of hilar bile duct cancer. Preoperative diagnosis, selection of treatment options and clinical outcome.
    Hirai I; Kimura W; Fuse A; Suto K; Sakurai F; Ishiyama S
    Hepatogastroenterology; 2003; 50(51):629-35. PubMed ID: 12828048
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The mode of lymphatic spread in carcinoma of the bile duct.
    Kurosaki I; Tsukada K; Hatakeyama K; Muto T
    Am J Surg; 1996 Sep; 172(3):239-43. PubMed ID: 8862075
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Histologic bile duct invasion by a mass-forming intrahepatic cholangiocarcinoma.
    Hirohashi K; Uenishi T; Kubo S; Yamamoto T; Tanaka H; Shuto T; Yamasaki O; Horii K; Kinoshita H
    J Hepatobiliary Pancreat Surg; 2002; 9(2):233-6. PubMed ID: 12140612
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intrahepatic peripheral cholangiocarcinoma: mode of spread and choice of surgical treatment.
    Sasaki A; Aramaki M; Kawano K; Morii Y; Nakashima K; Yoshida T; Kitano S
    Br J Surg; 1998 Sep; 85(9):1206-9. PubMed ID: 9752860
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinicopathological characteristics of hepatic hilar bile duct carcinoma.
    Kimura W; Nagai H; Atomi Y; Kuroda A; Muto T; Yamashiro M; Esaki Y
    Hepatogastroenterology; 1993 Feb; 40(1):21-7. PubMed ID: 8462923
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinicopathologic features in patients with long-term survival following resection for intrahepatic cholangiocarcinoma.
    Uenishi T; Hirohashi K; Kubo S; Yamamoto T; Yamazaki O; Shuto T; Tanaka H; Kinoshita H
    Hepatogastroenterology; 2003; 50(52):1069-72. PubMed ID: 12845984
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Histological appearance of carcinoma of the upper bile duct and the mode of its spread].
    Ouchi K; Suzuki M; Matsuno S; Sato T
    Nihon Geka Gakkai Zasshi; 1987 Jul; 88(7):845-51. PubMed ID: 3670270
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aggressive surgical resection for hilar-invasive and peripheral intrahepatic cholangiocarcinoma.
    Nakagohri T; Asano T; Kinoshita H; Kenmochi T; Urashima T; Miura F; Ochiai T
    World J Surg; 2003 Mar; 27(3):289-93. PubMed ID: 12607053
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognosis of perihilar cholangiocarcinoma: hilar bile duct cancer versus intrahepatic cholangiocarcinoma involving the hepatic hilus.
    Sano T; Shimada K; Sakamoto Y; Ojima H; Esaki M; Kosuge T
    Ann Surg Oncol; 2008 Feb; 15(2):590-9. PubMed ID: 18057991
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serosal invasion in TNM staging of mass-forming intrahepatic cholangiocarcinoma.
    Uenishi T; Yamazaki O; Yamamoto T; Hirohashi K; Tanaka H; Tanaka S; Hai S; Kubo S
    J Hepatobiliary Pancreat Surg; 2005; 12(6):479-83. PubMed ID: 16365823
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proposal of progression model for intrahepatic cholangiocarcinoma: clinicopathologic differences between hilar type and peripheral type.
    Aishima S; Kuroda Y; Nishihara Y; Iguchi T; Taguchi K; Taketomi A; Maehara Y; Tsuneyoshi M
    Am J Surg Pathol; 2007 Jul; 31(7):1059-67. PubMed ID: 17592273
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation between tumor size and mode of spread in mass-forming intrahepatic cholangiocarcinoma.
    Sasaki A; Kawano K; Aramaki M; Ohno T; Tahara K; Kitano S
    Hepatogastroenterology; 2004; 51(55):224-8. PubMed ID: 15011869
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinicopathological features of "intraductal papillary neoplasm of the bile duct" and patient outcome after surgical resection.
    Nanashima A; Kinoshita N; Nakanuma Y; Zen Y; Sumida Y; Abo T; Hidaka S; Takeshita H; Yasutake T; Hayashi T; Nagayasu T
    Hepatogastroenterology; 2008; 55(85):1167-73. PubMed ID: 18795651
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Study of the intrahepatic surgical margin of hilar bile duct carcinoma.
    Okazaki Y; Horimi T; Kotaka M; Morita S; Takasaki M
    Hepatogastroenterology; 2002; 49(45):625-7. PubMed ID: 12063955
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A national survey of 1098 cases with extrahepatic biliary cancer].
    Zhonghua Wai Ke Za Zhi; 1990 Sep; 28(9):516-21, 572. PubMed ID: 2086121
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primary mucoepidermoid carcinoma of the intrahepatic bile duct: a case report with review of literature.
    Shuangshoti S; Shuangshoti S
    J Med Assoc Thai; 2000 Feb; 83(2):197-203. PubMed ID: 10710890
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Macroscopic types of intrahepatic cholangiocarcinoma: clinicopathologic features and surgical outcomes.
    Hirohashi K; Uenishi T; Kubo S; Yamamoto T; Tanaka H; Shuto T; Kinoshita H
    Hepatogastroenterology; 2002; 49(44):326-9. PubMed ID: 11995443
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The clinico-morphological characteristics of cancer of the extrahepatic bile ducts (an analysis of 52 autopsy cases)].
    Samsonov VA; Andreeva RM; Fedorova LA; Nekachalov VV
    Ter Arkh; 1995; 67(10):53-5. PubMed ID: 8779108
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.